Ketorolac Tromethamine Injection, Solution
Product Images NDC 43066-049

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 43066-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01-container-label-15mg-ml-sd (Image 01 Container Label 15mg mL Sd)

This description provides details about a prescription drug called Ketorolac Tromethamine in the form of an injection designated for intravenous or intramuscular use. The drug is contained in a 1 mL single-dose vial with specific directions to discard any remaining unused portion. The manufacturer is Baxter Healthcare Corporation located in Deerfield, IL, and the drug was made in India. The expiration date given is 02/2026. It has a unique identification number: NDC 43066-049-01. The package includes an unvarnished area with dimensions of 17 x 7 mm. The last line on the package is ALKTR15VUS.*

FDA Label Image

Image-01 (Image 01)

FDA Label Image

Image-02-outer-carton-label-15mg-ml (Image 02 Outer Carton Label 15mg mL)

This is a product label for Ketorolac Tromethamine Injection, USP used for intravenous or intramuscular administration. Each package contains 10 single-dose vials of 1 mL. The medication guide should be dispensed to each patient. The product is manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, for Baxter Healthcare Corporation in the USA. The GTIN code for this product is 20343066049106. It is a prescription-only medication (Rx only) with NDC number 43066-049-10.*

FDA Label Image

Image-03-container-label-30 mg-ml-sd (Image 03 Container Label 30 mg mL Sd)

This is a description of a prescription medication called Ketorolac Tromethamine in injection form, intended for Intravenous/Intramuscular use. The product comes in a 1 mL Single Dose Vial and should be discarded if any portion remains unused. The medication is produced for Baxter Healthcare Corporation located in Deerfield, Illinois, USA. The text also includes manufacturing information and expiration date.*

FDA Label Image

Image-04-outer-carton-label-30mg-ml (Image 04 Outer Carton Label 30mg mL)

FDA Label Image

Image-05-container-label-60mg-ml-sd (Image 05 Container Label 60mg mL Sd)

This text provides information on a medication called Ketorolac Tromethamine in the form of a 60 mg/2 mL injection for intramuscular use. The medication is contained in a 2 mL single-dose vial with specific manufacturing details including being made for Baxter Healthcare Corporation in the USA and manufactured in India with a specific code GUJ/DRUGS/G/28/1704. The expiration date is 02/2026, and the LOT number is provided as 20047196. The text also includes a warning to discard any unused portion and mentions that the medication is for prescription use only.*

FDA Label Image

Image-06-outer-carton-label-30mg-ml (Image 06 Outer Carton Label 30mg mL)

This is the description based on the text: This text contains information about a Ketorolac Tromethamine Injection, USP with a strength of 60 mg/2 mL (30 mg/mL), intended for intramuscular use only. The batch details indicate a specific barcode for tracking purposes. The product may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The usual storage conditions are between 20°C to 25°C (68°F to 77°F), and any unused portion should be discarded. The manufacturer is Alembic Pharmaceuticals Limited in Gujarat, INDIA. The dosage instructions are available in the package insert, and each patient should receive the enclosed Medication Guide.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.